Answers are grounded in this paper and cite their sources.
This paper determines the optimal conditions for the directed biocatalytic oxidation of β-sitosterol by actinobacilli of the genus Rhodococcus to compounds claimed in the pharmaceutical practice: stigmast-4-en-3-one, androst-4-ene-3.17-dione, and androsta-1.4-diene-3.17-dione. Rhodococci were ascertained to convert approximately 98.0% of β-sitosterol into stigmast-4-en-3-one in the presence of n-hexadecane. The cells of rhodococci preliminarily adapted to β-sitosterol catalyze the reaction of the removal of the aliphatic lateral β-sitosterol chain with the formation of 31.5% of androstan derivatives in the presence of glucose and 2.2′-dipyridyl that is the inhibitor of 9α-hydroxylase. It was discovered for the first time that cells of R. ruber catalyzed the reaction of sterol acylation with the formation of β-sitosterol acetate along with oxidative processes.
No takes yet. Share an insight, caveat, or question.
Grishko et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: